Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yixie Zhang

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Developmental Cell|February 28, 2018
Organizing Complex Tissue Architecture by Pushing and Pulling Cell ContactsYixie Zhang, Tony J C Harris
Targeted Oncology|April 19, 2023
Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature ReviewMelody Zhao, Kent A Hanson, Yixie Zhang, et al.
Developmental Cell|May 29, 2018
Collision of Expanding Actin Caps with Actomyosin Borders for Cortical Bending and Mitotic Rounding in a SyncytiumYixie Zhang, Jessica C Yu, Tao Jiang, et al.
Journal of Hematology & Oncology|September 8, 2021
Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphomaDavid G Maloney, John Kuruvilla, Fei Fei Liu, et al.
Experimental Hematology & Oncology|March 26, 2022
Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucelGuillaume Cartron, Christopher P Fox, Fei Fei Liu, et al.
Leukemia & Lymphoma|July 25, 2025
Matching-adjusted indirect comparison of lisocabtagene maraleucel versus axicabtagene ciloleucel for second-line treatment of patients with early relapsed or refractory large B-cell lymphomaJeremy S Abramson, Manali Kamdar, Fei Fei Liu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Developmental Cell|February 28, 2018
Organizing Complex Tissue Architecture by Pushing and Pulling Cell ContactsYixie Zhang, Tony J C Harris
Targeted Oncology|April 19, 2023
Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature ReviewMelody Zhao, Kent A Hanson, Yixie Zhang, et al.
Developmental Cell|May 29, 2018
Collision of Expanding Actin Caps with Actomyosin Borders for Cortical Bending and Mitotic Rounding in a SyncytiumYixie Zhang, Jessica C Yu, Tao Jiang, et al.
Journal of Hematology & Oncology|September 8, 2021
Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphomaDavid G Maloney, John Kuruvilla, Fei Fei Liu, et al.
Experimental Hematology & Oncology|March 26, 2022
Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucelGuillaume Cartron, Christopher P Fox, Fei Fei Liu, et al.
Leukemia & Lymphoma|July 25, 2025
Matching-adjusted indirect comparison of lisocabtagene maraleucel versus axicabtagene ciloleucel for second-line treatment of patients with early relapsed or refractory large B-cell lymphomaJeremy S Abramson, Manali Kamdar, Fei Fei Liu, et al.
Pageof 1